Rupal K Jaffa
Rupal K Jaffa publishes mostly in Pharmacology, Infectious Diseases and Epidemiology, on topics such as Drug-Induced Adverse Reactions, Antibiotic Use and Resistance and Antibiotics Pharmacokinetics and Efficacy.
- World rank
- #6,796,967 of 7,710,434 ranked researchers
- Rank in United States
- #1,556,377 of 1,627,098
- Works
- 22
- Citations
- 51
- Citations per work
- 2.3
What does Rupal K Jaffa research?
Rupal K Jaffa's work is mostly in Medicine (55%), Immunology and Microbiology (8%), Pharmacology, Toxicology and Pharmaceutics (5%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences1254.7%
- Medicine1254.7%
- Everything else732.8%
- Life Sciences312.5%
- 1Pharmacology19% of their works
- 2Infectious Diseases17% of their works
- 3Epidemiology11% of their works
- 4Applied Microbiology and Biotechnology8% of their works
- 5Surgery8% of their works
- 6Toxicology5% of their works
Research topics
- Drug-Induced Adverse Reactions
- Antibiotic Use and Resistance
- Antibiotics Pharmacokinetics and Efficacy
- Pharmacovigilance and Adverse Drug Reactions
- Antimicrobial Resistance in Staphylococcus
- Bacterial Identification and Susceptibility Testing
- Antibiotic Resistance in Bacteria
- Pneumocystis jirovecii pneumonia detection and treatment
Which keywords describe Rupal K Jaffa's research?
The keywords of their largest research topics: Epidemiology, Antimicrobial Resistance, Antibiotic Resistance, HLA-B*5701, Stevens-Johnson Syndrome, Antibiotic Pharmacokinetics, Antimicrobial Stewardship and Critically Ill Patients.
- Pneumocystis
- Microorganism Identification
- ESKAPE Pathogens
- Pharmacovigilance
- Adverse Drug Reactions
- Critically Ill Patients
- Antibiotic Pharmacokinetics
- HLA-B*5701
- Antimicrobial Resistance
- Epidemiology
- Antibiotic Resistance
- Stevens-Johnson Syndrome
- Antimicrobial Stewardship
- Global Health
- MRSA
- Staphylococcus aureus
- Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry
- Multidrug-Resistant Bacteria
- Pneumonia
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 19 words, with their numbers
- Epidemiology103 topics
- Antimicrobial Resistance82 topics
- Antibiotic Resistance72 topics
- HLA-B*570171 topic
- Stevens-Johnson Syndrome71 topic
- Antibiotic Pharmacokinetics51 topic
- Antimicrobial Stewardship51 topic
- Critically Ill Patients51 topic
- Global Health51 topic
- Adverse Drug Reactions31 topic
- MRSA31 topic
- Pharmacovigilance31 topic
- Staphylococcus aureus31 topic
- ESKAPE Pathogens21 topic
- Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry21 topic
- Microorganism Identification21 topic
- Multidrug-Resistant Bacteria21 topic
- Pneumocystis21 topic
- Pneumonia21 topic
Where does Rupal K Jaffa work?
Rupal K Jaffa's main affiliation in the publication record is Atrium Medical Cente, United States.
How many publications and citations does Rupal K Jaffa have?
OpenAlex counts 22 works and 51 citations for Rupal K Jaffa, an h-index of 4, ranking #6,796,967 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Rupal K Jaffa. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.